A HYNI
C-
conjugated
chemota
cti
c peptide (fMLFK-HYNIC) was labeled with
99mT
c using tri
cine andTPPTS as
coligands. The
combination of fMLFK-HYNIC, tri
cine, and TPPTS with
99mT
c produ
ced aternary ligand
complex [
99mT
c(fMLFK-HYNIC)(tri
cine)(TPPTS)] (RP463). RP463 was synthesized eitherin two steps, in whi
ch the binary ligand
complex [
99mT
c(fMLFK-HYNIC)(tri
cine)
2] (RP469) was formedfirst and then rea
cted with TPPTS, or in one step by dire
ct redu
ction of [
99mT
c]perte
chnetate withstannous
chloride in the presen
ce of fMLFK-HYNIC, tri
cine, and TPPTS. The radiolabeling yield forRP463 was usually
90% using 10
g of fMLFK-HYNIC and 100 mCi of [
99mT
c]perte
chnetate. UnlikeRP469, whi
ch de
composed rapidly in the absen
ce of ex
cess tri
cine
coligand, RP463 was stable in solutionfor at least 6 h. [
99T
c]RP463 was prepared and
chara
cterized by HPLC and ele
ctrospray massspe
ctrometry. In an in vitro assay, [
99T
c]RP463 showed an IC
50 of 2 nM against binding of [
3H]fMLFto re
ceptors on PMNs. [
99T
c]RP463 also indu
ces effe
ctively the superoxide release of polymorphonu
clearleuko
cytes (PMNs) with an EC
50 value of 0.2 ± 0.2 nM. The lo
calization of RP463 in the infe
ction fo
ciwas assessed in a rabbit infe
ction model. RP463 was
cleared from the blood faster than RP469 andwas ex
creted mainly through the renal system. As a result of rapid blood
clearan
ce and in
creaseduptake, the target-to-ba
ckground ratios
continuously in
creased from 1.5 ± 0.2 at 15 min postinje
ctionto 7.5 ± 0.4 at 4 h postinje
ction. Visualization of the infe
cted area
could be as early as 2 h. A transientde
crease in white blood
cell
count of 35% was observed during the first 30 min after inje
ction of theHPLC-purified RP463 in the infe
cted rabbit. This suggests that future resear
ch in this area shouldfo
cus on developing highly potent antagonists for
chemota
cti
c peptide re
ceptor or other re
ceptors onPMNs and mono
cytes.